Antimicrobial resistance represents one of medicine's most pressing challenges, with inappropriate antibiotic prescribing for viral respiratory infections contributing significantly to this crisis. The ability to definitively distinguish viral from bacterial infections at the point of care could transform treatment decisions and preserve antibiotic effectiveness for future generations.
A controlled trial involving 771 pediatric patients with acute respiratory illness examined whether rapid viral testing influences prescribing patterns. The study compared outcomes between children receiving advanced Xpert Xpress testing for influenza and RSV versus standard influenza antigen testing. While overall antibiotic prescribing remained similar between groups, specific viral identifications led to targeted changes in treatment approaches. Children testing positive for influenza B showed decreased antibiotic use and increased antiviral prescriptions in both testing groups. Most notably, RSV-positive patients in the advanced testing group experienced a dramatic reduction in cephalosporin prescriptions, dropping from 17.4% to 2.2%.
This research adds to mounting evidence that rapid pathogen identification can guide more judicious antibiotic use, particularly crucial as respiratory tract infections account for millions of unnecessary antibiotic prescriptions annually. The findings suggest that point-of-care molecular diagnostics may serve as valuable stewardship tools, especially for specific viral infections like RSV where antibiotics provide no benefit. However, the study's focus on pediatric outpatients and relatively modest overall impact indicate that diagnostic technology alone cannot solve inappropriate prescribing patterns. Broader implementation would require addressing physician decision-making factors beyond test availability, including patient expectations and diagnostic uncertainty in complex cases.